ReviewNaunyn-Schmiedeberg's archives of pharmacology2026

EGFR-targeted tyrosine kinase inhibitors: advancements in cancer therapy.

Shaheen Ali et al.PubMed ↗Publisher ↗

No numbers read from the abstract.